ArticleCell death & disease2018

Can we conclude a potential therapeutic action for Parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?

Juan Segura-AguilarPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.